Cargando…

Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models

Glycosylation is one of the most common protein modifications in living organisms and has important regulatory roles in animal tissue development and homeostasis. Here, we present a protocol for generation of 3D organotypic skin models using CRISPR-Cas9 genetically engineered human keratinocytes (N/...

Descripción completa

Detalles Bibliográficos
Autores principales: Marinova, Irina N., Wandall, Hans H., Dabelsteen, Sally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403582/
https://www.ncbi.nlm.nih.gov/pubmed/34485933
http://dx.doi.org/10.1016/j.xpro.2021.100668
_version_ 1783746029742456832
author Marinova, Irina N.
Wandall, Hans H.
Dabelsteen, Sally
author_facet Marinova, Irina N.
Wandall, Hans H.
Dabelsteen, Sally
author_sort Marinova, Irina N.
collection PubMed
description Glycosylation is one of the most common protein modifications in living organisms and has important regulatory roles in animal tissue development and homeostasis. Here, we present a protocol for generation of 3D organotypic skin models using CRISPR-Cas9 genetically engineered human keratinocytes (N/TERT-1) to study the role of glycans in epithelial tissue formation. This strategy is also applicable to other gene targets and organotypic tissue models. Careful handling of the cell cultures is critical for the successful formation of the organoids. For complete details on the use and execution of this protocol, please refer to Dabelsteen et al. (2020).
format Online
Article
Text
id pubmed-8403582
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84035822021-09-02 Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models Marinova, Irina N. Wandall, Hans H. Dabelsteen, Sally STAR Protoc Protocol Glycosylation is one of the most common protein modifications in living organisms and has important regulatory roles in animal tissue development and homeostasis. Here, we present a protocol for generation of 3D organotypic skin models using CRISPR-Cas9 genetically engineered human keratinocytes (N/TERT-1) to study the role of glycans in epithelial tissue formation. This strategy is also applicable to other gene targets and organotypic tissue models. Careful handling of the cell cultures is critical for the successful formation of the organoids. For complete details on the use and execution of this protocol, please refer to Dabelsteen et al. (2020). Elsevier 2021-07-10 /pmc/articles/PMC8403582/ /pubmed/34485933 http://dx.doi.org/10.1016/j.xpro.2021.100668 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Protocol
Marinova, Irina N.
Wandall, Hans H.
Dabelsteen, Sally
Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models
title Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models
title_full Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models
title_fullStr Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models
title_full_unstemmed Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models
title_short Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models
title_sort protocol for crispr-cas9 modification of glycosylation in 3d organotypic skin models
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403582/
https://www.ncbi.nlm.nih.gov/pubmed/34485933
http://dx.doi.org/10.1016/j.xpro.2021.100668
work_keys_str_mv AT marinovairinan protocolforcrisprcas9modificationofglycosylationin3dorganotypicskinmodels
AT wandallhansh protocolforcrisprcas9modificationofglycosylationin3dorganotypicskinmodels
AT dabelsteensally protocolforcrisprcas9modificationofglycosylationin3dorganotypicskinmodels